MML Investors Services’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,829
Closed -$222K 2798
2024
Q4
$222K Buy
+1,829
New +$224K ﹤0.01% 2452
2024
Q3
Sell
-8,574
Closed -$1.35M 2629
2024
Q2
$1.35M Buy
+8,574
New +$1.1M 0.01% 1239
2021
Q1
Sell
-3,268
Closed -$557K 1838
2020
Q4
$557K Sell
3,268
-65
-2% -$9.63K 0.01% 1104
2020
Q3
$468K Sell
3,333
-107
-3% -$16.3K 0.01% 1074
2020
Q2
$552K Sell
3,440
-1,871
-35% -$255K 0.01% 949
2020
Q1
$520K Buy
+5,311
New +$607K 0.01% 846
2019
Q3
Sell
-2,230
Closed -$339K 1594
2019
Q2
$339K Buy
2,230
+167
+8% +$20.3K ﹤0.01% 1216
2019
Q1
$246K Buy
2,063
+223
+12% +$28.7K ﹤0.01% 1369
2018
Q4
$201K Sell
1,840
-339
-16% -$42.4K ﹤0.01% 1382
2018
Q3
$352K Buy
2,179
+299
+16% +$40.9K 0.01% 1195
2018
Q2
$248K Sell
1,880
-864
-31% -$81.5K 0.01% 1170
2018
Q1
$203K Sell
2,744
-6,282
-70% -$419K ﹤0.01% 1276
2017
Q4
$502K Sell
9,026
-1,383
-13% -$73.3K 0.01% 838
2017
Q3
$472K Buy
10,409
+2,297
+28% +$91.8K 0.01% 809
2017
Q2
$273K Buy
+8,112
New +$264K 0.01% 1021

Other funds holding SRPT

MML Investors Services's SRPT Position: Q1 2025 in Review

MML Investors Services sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 1,829 shares — an estimated $222K sold.

MML Investors Services first reported a position in SRPT in Q2 2017 and held it in 15 quarters. The position peaked at $1.35M in Q2 2024. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.

  • MML Investors Services reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
  • MML Investors Services sold 1,829 Sarepta Therapeutics shares in Q1 2025, an estimated $222K.
  • MML Investors Services first reported a position in Sarepta Therapeutics in Q2 2017 and held it in 15 quarters.
  • MML Investors Services's Sarepta Therapeutics position peaked at $1.35M in Q2 2024.
  • 430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.

Based on MML Investors Services's 13F filing for Q1 2025, filed 14 May 2025.